Papers - YONEYAMA Tohru
-
Analytical and Real-World Clinical Characterization of S2,3PSA% Test in MRI Fusion Targeted Prostate Biopsy Population.
Yuki Miura, Tohru Yoneyama, Hayato Yamamoto, Hiromu Suzuki, Takuma Otsubo, Eriko Fujita, Fumiyasu Tsushima, Shintaro Goto, Teppei Okamoto, Naoki Fujita, Masahiro Ishiyama, Tadashi Yoshizawa, Shingo Kakeda, Shingo Hatakeyama, Chikara Ohyama
The Prostate 85 ( 9 ) 869 - 887 2025.3
-
PD-L1 and Ki-67 Expression Before and After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
Sasaki D, Yoneyama T, Yoneyama F, Ozaki K, Ozaki Y, Miura Y, Fujita N, Okamoto T, Yamamoto H, Goto S, Yoshizawa T, Kurose A, Kijima H, Ohyama C, Hatakeyama S
International journal of urology : official journal of the Japanese Urological Association 2025.5
-
The Effects of the Blood-Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies.
Miura H, Hamaya T, Yoneyama T, Shimoyama T, Tsushima F, Togashi K, Miura Y, Yoneyama A, Sato H, Omizo S, Mori K, Kodama H, Fujita N, Okamoto T, Yamamoto H, Kakeda S, Ohyama C, Hatakeyama S
The Prostate 2025.5
-
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter Study.
Ozaki K, Yamamoto H, Sekine Y, Horiguchi H, Hosogoe S, Mikami J, Fujita N, Tokui N, Okita K, Okamoto T, Mori K, Kobayashi M, Numakura K, Yoneyama T, Tabata R, Sato S, Habuchi T, Ohyama C, Hatakeyama S
International journal of urology : official journal of the Japanese Urological Association 2025.3
-
特集 今のうちにしっかり理解 最新の前立腺癌診療と近未来予想図 〈診断〉 PSAを超えるバイオマーカーS2,3PSA%検査の実力
米山 徹
臨床泌尿器科 79 ( 1 ) 6 - 14 2025.1
-
PhiとSi,3PSA%の監視療法におけるプロトコール生検の再分類予測の検討 PRIAS-JAPAN
加藤 琢磨, 米山 徹, 畠山 真悟, 佐藤 琢磨, 松本 隆児, 森 啓一郎, 谷川 俊貴, 坂本 信一, 井上 雅晴, 土肥 洋一郎, 福原 浩, 納谷 幸男, 大山 力, 杉元 幹史
日本癌治療学会学術集会抄録集 62回 O21 - 6 2024.10
-
α2,3シアル化PSAとα1,6フコシル化PSAを組み合わせたSF indexによる前立腺癌診断
波多野 浩士, 米山 徹, 畠山 真吾, 冨山 栄輔, 土屋 睦美, 西本 光寿, 吉村 一宏, 三善 英知, 植村 天受, 大山 力, 野々村 祝夫, 藤田 和利
泌尿器外科 37 ( 8 ) 919 - 920 2024.8
-
TOPICS 泌尿器科学 前立腺癌の新規体外診断薬S2,3PSA%
大山 力, 米山 徹, 畠山 真吾
医学のあゆみ 290 ( 2 ) 182 - 183 2024.7
-
トピックス 新規前立腺癌診断マーカー S2,3PSA%の有用性
畠山 真吾, 米山 徹, 大山 力
検査と技術 52 ( 6 ) 568 - 570 2024.6
-
Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab.
Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Kazuyuki Mori, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama
Scientific reports 13 ( 1 ) 15098 - 15098 2023.9
-
Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study.
Okuyama Y, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka T, Fujita N, Okamoto T, Mori K, Yamamoto H, Yoneyama T, Hashimoto Y, Matsuoka T, Sato S, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 30 ( 8 ) 649 - 657 2023.5
-
Summary of the clinical practice manual for late-onset hypogonadism.
Ide H, Akehi Y, Fukuhara S, Ohira S, Ogawa S, Kataoka T, Kumagai H, Kobayashi K, Komiya A, Shigehara K, Syuto T, Soh J, Tanabe M, Taniguchi H, Chiba K, Matsushita K, Mitsui Y, Yoneyama T, Shirakawa T, Fujii Y, Kumano H, Ueshiba H, Amano T, Sasaki H, Maeda S, Mizokami A, Suzuki K, Horie S
International journal of urology : official journal of the Japanese Urological Association 30 ( 5 ) 422 - 430 2023.5
-
Relationship between lower urinary tract symptoms and frailty.
Ozaki Y, Hatakeyama S, Imai A, Songee J, Soma O, Ozaki K, Fujita N, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 30 ( 7 ) 606 - 613 2023.4
-
Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG.
Numakura K, Miyake M, Kobayashi M, Muto Y, Sekine Y, Nishimura N, Iida K, Shiga M, Morizane S, Yoneyama T, Matsumura Y, Abe T, Yamada T, Matsumoto K, Inokuchi J, Nishiyama N, Taoka R, Kobayashi T, Kojima T, Kitamura H, Nishiyama H, Fujimoto K, Habuchi T
Cancers 15 ( 7 ) 2023.3
-
Trends in the age of hospitalized patients with urological cancers: A 17-year experience.
Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 30 ( 7 ) 572 - 578 2023.3
-
Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy.
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Fukuda M, Shinozaki T, Ishii N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C
Scientific reports 13 ( 1 ) 3436 2023.3
-
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.
Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 12 ( 2 ) 161 - 167 2023.2
-
Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study.
Fujita N, Momota M, Horiguchi H, Hamano I, Mikami J, Hatakeyama S, Ito H, Yoneyama T, Hashimoto Y, Nishimura S, Yoshikawa K, Ohyama C
Cancers 15 ( 5 ) 2023.2
-
Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study.
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C
The Prostate 83 ( 2 ) 198 - 203 2023.2
-
Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.
Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
PloS one 18 ( 2 ) e0275921 2023.2